This content is from:APP亚博娱乐
Teva Secures $1.5B Credit Facility
Teva Pharmaceutical Industries has secured a credit facility worth $1.5 billion.
Teva Pharmaceutical Industrieshas secured a credit facility worth $1.5 billion,Bloombergreports. The Israeli pharmaceutical company will refinance its debt at more favorable terms for the unsecured revolving loan.
CitigroupandHSBC Holdingsare co-coordinators and book-runners of the three-year term credit line.Barclays Capital,BNP Paribas,Credit Suisse,Goldman Sachs,JPMorgan Chase,Morgan Stanley,BankHapoalim BMandBank Leumi Le-Israelare acting as lenders to Teva during the deal’s syndication.
Click here for the story fromBloomberg.
Click here for additional coverage fromReuters.